HHS Spent $49.6M on Pediatric Flu Vaccines from GlaxoSmithKline in 2014-2015

Contract Overview

Contract Amount: $49,597,928 ($49.6M)

Contractor: Glaxosmithkline, LLC

Awarding Agency: Department of Health and Human Services

Start Date: 2014-02-05

End Date: 2015-02-28

Contract Duration: 388 days

Daily Burn Rate: $127.8K/day

Competition Type: FULL AND OPEN COMPETITION

Number of Offers Received: 5

Pricing Type: FIRM FIXED PRICE

Sector: Healthcare

Official Description: PEDIATRIC FLU VACCINES 2014-2015

Place of Performance

Location: DURHAM, DURHAM County, NORTH CAROLINA, 27709

State: North Carolina Government Spending

Plain-Language Summary

Department of Health and Human Services obligated $49.6 million to GLAXOSMITHKLINE, LLC for work described as: PEDIATRIC FLU VACCINES 2014-2015 Key points: 1. The contract awarded $49.6 million for pediatric flu vaccines. 2. GlaxoSmithKline, LLC was the sole awardee. 3. The contract was awarded under full and open competition. 4. The contract type was Firm Fixed Price. 5. The contract duration was 388 days.

Value Assessment

Rating: good

The total award amount of $49.6 million for pediatric flu vaccines appears reasonable given the quantity and the nature of pharmaceutical products. Benchmarking against similar public health vaccine procurements would provide further context.

Cost Per Unit: N/A

Competition Analysis

Competition Level: full-and-open

The contract was awarded through full and open competition, suggesting a competitive bidding process. This method generally promotes price discovery and can lead to more favorable pricing for the government.

Taxpayer Impact: Taxpayers benefited from a competitive process likely securing a fair price for essential pediatric flu vaccines.

Public Impact

Ensures availability of critical pediatric flu vaccines for public health. Supports disease prevention efforts for a vulnerable population. Contributes to the overall health and well-being of children. Demonstrates government commitment to seasonal public health initiatives.

Waste & Efficiency Indicators

Waste Risk Score: 50 / 10

Positive Signals

Full and open competition utilized.
Firm Fixed Price contract type.
Procurement supports critical public health need.

Sector Analysis

This procurement falls within the Healthcare sector, specifically related to pharmaceutical manufacturing and distribution. Spending on seasonal vaccines is a recurring public health expenditure.

Small Business Impact

The data does not indicate whether small businesses were involved in the subcontracting or supply chain for this contract. Further analysis would be needed to assess small business participation.

Oversight & Accountability

The Centers for Disease Control and Prevention (CDC) managed this procurement. Standard government oversight processes for pharmaceutical contracts would apply.

Related Government Programs

Pharmaceutical Preparation Manufacturing
Department of Health and Human Services Contracting
Centers for Disease Control and Prevention Programs

Frequently Asked Questions

What is this federal contract paying for?

Department of Health and Human Services awarded $49.6 million to GLAXOSMITHKLINE, LLC. PEDIATRIC FLU VACCINES 2014-2015

Who is the contractor on this award?

The obligated recipient is GLAXOSMITHKLINE, LLC.

Which agency awarded this contract?

Awarding agency: Department of Health and Human Services (Centers for Disease Control and Prevention).

What is the total obligated amount?

The obligated amount is $49.6 million.

What is the period of performance?

Start: 2014-02-05. End: 2015-02-28.

What was the per-unit cost of the pediatric flu vaccines?

The provided data does not include the specific number of vaccine units procured, only the total award amount of $49.6 million. Therefore, a precise per-unit cost cannot be calculated without additional information on the quantity of vaccines purchased under this contract.

Were there any quality control issues or recalls associated with these vaccines?

The provided data does not contain information regarding quality control issues or recalls for the pediatric flu vaccines procured under this contract. Such details would typically be found in post-award performance reports or agency-specific databases.

How does the pricing compare to other flu vaccine contracts awarded around the same time?

Without access to a broader dataset of flu vaccine contracts from the 2014-2015 period, a direct price comparison is not possible. However, the contract was awarded under full and open competition, suggesting that the pricing was likely competitive at the time of award.

Industry Classification

NAICS: Manufacturing › Pharmaceutical and Medicine Manufacturing › Pharmaceutical Preparation Manufacturing

Product/Service Code: MEDICAL/DENTAL/VETERINARY EQPT/SUPP

Competition & Pricing

Extent Competed: FULL AND OPEN COMPETITION

Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE

Solicitation ID: 2013N15756

Offers Received: 5

Pricing Type: FIRM FIXED PRICE (J)

Evaluated Preference: NONE

Contractor Details

Parent Company: Glaxosmithkline PLC

Address: 5 MOORE DR, RESEARCH TRIANGLE PARK, NC, 27709

Business Categories: Category Business, Corporate Entity Not Tax Exempt, Limited Liability Corporation, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Financial Breakdown

Contract Ceiling: $81,549,966

Exercised Options: $81,549,966

Current Obligation: $49,597,928

Contract Characteristics

Commercial Item: COMMERCIAL PRODUCTS/SERVICES

Cost or Pricing Data: NO

Timeline